ConductScience.org, home

Paper435698

The response of six mouse tumours to combined heat and X rays: implications for therapy.

Hill SA and 1 other. Br J Radiol, 1979. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. The response of six mouse tumours to combined heat and X rays: implications for therapy. Papers, record 435698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/435698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The response of six mouse tumours to combined heat and X rays: implications for therapy.
PubMed
Journal
Br J Radiol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.58
iCite
Revised in PubMed
2008-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hill SAS A
2Denekamp JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hot TemperatureMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Carcinoma, Squamous Cell
Dose-Response Relationship, Radiation
Mammary Neoplasms, Experimental
Mice
Time Factors
X-Ray Therapy

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
39682105The Rationale for Combining Hypofractionated Radiation and Hyperthermia.Cancers (Basel)2024https://conductscience.org/library/papers/39682105PubMed
35565180The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells.Cancers (Basel)2022https://conductscience.org/library/papers/35565180PubMed
26245485Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.Radiat Oncol2015https://conductscience.org/library/papers/26245485PubMed
7326192Interactions between misonidazole and hyperthermia in EMT6 spheroids.Br J Cancer1981https://conductscience.org/library/papers/7326192PubMed
7000125Is any single in situ assay of tumour response adequate?Br J Cancer Suppl1980https://conductscience.org/library/papers/7000125PubMed
6758828Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.Br J Cancer1982https://conductscience.org/library/papers/6758828PubMed
6201181Endothelial proliferation in tumours and normal tissues: continuous labelling studies.Br J Cancer1984https://conductscience.org/library/papers/6201181PubMed
3355762Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.Br J Cancer1988https://conductscience.org/library/papers/3355762PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/435698

GET https://conductscience.org/api/papers/v1/435698/authors